Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| C-Reactive Protein | 2 | 2020 | 147 | 1.380 |
Why?
|
| Albuminuria | 3 | 2020 | 76 | 1.370 |
Why?
|
| Atherosclerosis | 3 | 2020 | 131 | 1.000 |
Why?
|
| Macrophage Colony-Stimulating Factor | 2 | 2020 | 13 | 0.920 |
Why?
|
| Diabetic Nephropathies | 2 | 2023 | 53 | 0.920 |
Why?
|
| Vitamin D Deficiency | 1 | 2022 | 94 | 0.810 |
Why?
|
| Macrophages | 3 | 2020 | 431 | 0.800 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2020 | 127 | 0.750 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2022 | 160 | 0.720 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2020 | 84 | 0.720 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 120 | 0.700 |
Why?
|
| Endothelial Cells | 1 | 2020 | 296 | 0.620 |
Why?
|
| Cell Proliferation | 3 | 2020 | 1149 | 0.580 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2023 | 592 | 0.570 |
Why?
|
| Apoptosis | 2 | 2020 | 1317 | 0.560 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 628 | 0.560 |
Why?
|
| Diabetes Complications | 1 | 2014 | 91 | 0.460 |
Why?
|
| Kidney Failure, Chronic | 1 | 2014 | 231 | 0.410 |
Why?
|
| Podocytes | 1 | 2011 | 33 | 0.400 |
Why?
|
| Cell Count | 1 | 2011 | 129 | 0.400 |
Why?
|
| Nicotine | 2 | 2020 | 238 | 0.310 |
Why?
|
| Nutrition Surveys | 2 | 2020 | 228 | 0.280 |
Why?
|
| Male | 10 | 2020 | 18870 | 0.260 |
Why?
|
| Aged | 4 | 2020 | 6448 | 0.230 |
Why?
|
| Parathyroid Hormone | 1 | 2022 | 36 | 0.220 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2022 | 22 | 0.220 |
Why?
|
| Disease Models, Animal | 4 | 2020 | 1300 | 0.220 |
Why?
|
| Mice, Knockout | 3 | 2020 | 897 | 0.220 |
Why?
|
| Cholecalciferol | 1 | 2022 | 19 | 0.220 |
Why?
|
| Fibroblast Growth Factors | 1 | 2022 | 34 | 0.220 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2022 | 63 | 0.210 |
Why?
|
| Mice, Inbred C57BL | 4 | 2020 | 1530 | 0.210 |
Why?
|
| Vitamins | 1 | 2022 | 91 | 0.210 |
Why?
|
| Female | 7 | 2020 | 19873 | 0.210 |
Why?
|
| Mice | 6 | 2020 | 5668 | 0.210 |
Why?
|
| Creatinine | 2 | 2019 | 101 | 0.200 |
Why?
|
| Middle Aged | 4 | 2020 | 9642 | 0.200 |
Why?
|
| Animal Feed | 1 | 2020 | 42 | 0.190 |
Why?
|
| Muscle Proteins | 1 | 2020 | 48 | 0.190 |
Why?
|
| Receptors, LDL | 1 | 2020 | 30 | 0.190 |
Why?
|
| Microfilament Proteins | 1 | 2020 | 64 | 0.190 |
Why?
|
| Cadherins | 1 | 2020 | 82 | 0.190 |
Why?
|
| Antigens, CD | 1 | 2020 | 116 | 0.190 |
Why?
|
| Aorta | 1 | 2020 | 161 | 0.180 |
Why?
|
| Urinalysis | 1 | 2019 | 31 | 0.180 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 424 | 0.170 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 137 | 0.170 |
Why?
|
| Humans | 8 | 2023 | 34853 | 0.170 |
Why?
|
| Zinc Fingers | 1 | 2018 | 25 | 0.170 |
Why?
|
| Nicotinic Agonists | 1 | 2019 | 68 | 0.170 |
Why?
|
| Adult | 3 | 2020 | 11034 | 0.170 |
Why?
|
| Stroke Volume | 1 | 2019 | 97 | 0.170 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 104 | 0.170 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2019 | 88 | 0.160 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 423 | 0.160 |
Why?
|
| Animals | 8 | 2020 | 14307 | 0.160 |
Why?
|
| Homeodomain Proteins | 1 | 2018 | 128 | 0.160 |
Why?
|
| Risk Assessment | 1 | 2020 | 727 | 0.150 |
Why?
|
| Incidence | 1 | 2019 | 882 | 0.150 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 841 | 0.140 |
Why?
|
| Carotid Artery Injuries | 1 | 2016 | 4 | 0.140 |
Why?
|
| Giant Cells | 1 | 2015 | 13 | 0.140 |
Why?
|
| Osteoclasts | 1 | 2015 | 13 | 0.140 |
Why?
|
| Carotid Artery Diseases | 1 | 2015 | 22 | 0.140 |
Why?
|
| Calcinosis | 1 | 2015 | 56 | 0.130 |
Why?
|
| Signal Transduction | 3 | 2020 | 1802 | 0.130 |
Why?
|
| Transcription Factors | 1 | 2018 | 653 | 0.120 |
Why?
|
| Glomerular Filtration Rate | 1 | 2014 | 137 | 0.120 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 2561 | 0.110 |
Why?
|
| Risk Factors | 1 | 2020 | 3414 | 0.110 |
Why?
|
| Microtomy | 1 | 2011 | 8 | 0.100 |
Why?
|
| Lipoproteins, LDL | 1 | 2011 | 61 | 0.100 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2011 | 88 | 0.100 |
Why?
|
| Staining and Labeling | 1 | 2011 | 100 | 0.100 |
Why?
|
| United States | 1 | 2020 | 3894 | 0.100 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 1426 | 0.090 |
Why?
|
| Estradiol | 1 | 2011 | 244 | 0.090 |
Why?
|
| Receptor, Melanocortin, Type 3 | 1 | 2009 | 6 | 0.090 |
Why?
|
| gamma-MSH | 1 | 2009 | 4 | 0.090 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 859 | 0.090 |
Why?
|
| Muscle Development | 1 | 2008 | 44 | 0.080 |
Why?
|
| Follistatin | 1 | 2008 | 27 | 0.080 |
Why?
|
| beta Catenin | 1 | 2008 | 46 | 0.080 |
Why?
|
| Androgens | 1 | 2008 | 87 | 0.080 |
Why?
|
| Receptors, Androgen | 1 | 2008 | 122 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 1 | 2008 | 183 | 0.080 |
Why?
|
| Kidney | 1 | 2009 | 322 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 968 | 0.070 |
Why?
|
| Blood Pressure | 1 | 2009 | 613 | 0.070 |
Why?
|
| Oxidative Stress | 2 | 2020 | 874 | 0.060 |
Why?
|
| Young Adult | 1 | 2014 | 4012 | 0.060 |
Why?
|
| Osteopontin | 1 | 2023 | 35 | 0.060 |
Why?
|
| Mecamylamine | 1 | 2020 | 14 | 0.050 |
Why?
|
| Neoplasm Transplantation | 1 | 2020 | 114 | 0.050 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2020 | 30 | 0.050 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2020 | 93 | 0.050 |
Why?
|
| Imidazoles | 1 | 2020 | 124 | 0.050 |
Why?
|
| Pyridines | 1 | 2020 | 113 | 0.050 |
Why?
|
| Neoplastic Stem Cells | 1 | 2020 | 74 | 0.050 |
Why?
|
| Inhalation Exposure | 1 | 2019 | 37 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2020 | 490 | 0.040 |
Why?
|
| DNA, Mitochondrial | 1 | 2019 | 165 | 0.040 |
Why?
|
| Myocytes, Cardiac | 1 | 2019 | 165 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 416 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 649 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2011 | 1442 | 0.040 |
Why?
|
| Inflammation | 1 | 2020 | 577 | 0.040 |
Why?
|
| Immunoblotting | 1 | 2016 | 170 | 0.030 |
Why?
|
| Rabbits | 1 | 2016 | 278 | 0.030 |
Why?
|
| Rats | 2 | 2016 | 3261 | 0.030 |
Why?
|
| Gene Expression | 1 | 2018 | 639 | 0.030 |
Why?
|
| Mutation | 1 | 2019 | 1023 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2015 | 197 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 2128 | 0.030 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2011 | 5 | 0.030 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2011 | 47 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 1534 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 445 | 0.020 |
Why?
|
| Rats, Inbred Dahl | 1 | 2009 | 30 | 0.020 |
Why?
|
| Telemetry | 1 | 2009 | 14 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 2009 | 66 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 2333 | 0.020 |
Why?
|
| Sodium, Dietary | 1 | 2009 | 25 | 0.020 |
Why?
|
| Proteinuria | 1 | 2009 | 48 | 0.020 |
Why?
|
| Monocytes | 1 | 2011 | 258 | 0.020 |
Why?
|
| Sodium | 1 | 2009 | 101 | 0.020 |
Why?
|
| TCF Transcription Factors | 1 | 2008 | 14 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2008 | 16 | 0.020 |
Why?
|
| Receptor Cross-Talk | 1 | 2008 | 16 | 0.020 |
Why?
|
| Orchiectomy | 1 | 2008 | 33 | 0.020 |
Why?
|
| Protein Transport | 1 | 2008 | 286 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2009 | 420 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2009 | 834 | 0.020 |
Why?
|
| Time Factors | 1 | 2011 | 1681 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2008 | 351 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 391 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 338 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2008 | 562 | 0.020 |
Why?
|